Business Description
Icure Pharmaceutical Inc
NAICS : 325412
SIC : 2834
ISIN : KR7175250000
Compare
Compare
Traded in other countries / regions
175250.Korea IPO Date
2018-07-12Description
Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.31 | |||||
| Debt-to-EBITDA | -4.29 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.04 | |||||
| Beneish M-Score | -6.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.7 | |||||
| 3-Year EBITDA Growth Rate | -99 | |||||
| 3-Year EPS without NRI Growth Rate | -47 | |||||
| 3-Year FCF Growth Rate | 36.7 | |||||
| 3-Year Book Growth Rate | -29.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.92 | |||||
| 9-Day RSI | 28.35 | |||||
| 14-Day RSI | 34.65 | |||||
| 6-1 Month Momentum % | 2.12 | |||||
| 12-1 Month Momentum % | -39.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.2 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 76.73 | |||||
| Days Sales Outstanding | 56.92 | |||||
| Days Payable | 39.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.6 | |||||
| Shareholder Yield % | 10.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 2.29 | |||||
| Operating Margin % | -39.88 | |||||
| Net Margin % | -55.31 | |||||
| FCF Margin % | -28.42 | |||||
| ROE % | -41.14 | |||||
| ROA % | -16.78 | |||||
| ROIC % | -10.3 | |||||
| ROC (Joel Greenblatt) % | -26.8 | |||||
| ROCE % | -27.11 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.21 | |||||
| PB Ratio | 1.17 | |||||
| Price-to-Tangible-Book | 1.54 | |||||
| EV-to-EBIT | -5.06 | |||||
| EV-to-EBITDA | -7.63 | |||||
| EV-to-Revenue | 2.39 | |||||
| EV-to-FCF | -8.46 | |||||
| Earnings Yield (Greenblatt) % | -19.77 | |||||
| FCF Yield % | -23.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Icure Pharmaceutical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 56,806.336 | ||
| EPS (TTM) (â‚©) | -836 | ||
| Beta | 1.08 | ||
| Volatility % | 48.83 | ||
| 14-Day RSI | 34.65 | ||
| 14-Day ATR (â‚©) | 69.572786 | ||
| 20-Day SMA (â‚©) | 1893.85 | ||
| 12-1 Month Momentum % | -39.81 | ||
| 52-Week Range (â‚©) | 1775 - 3595 | ||
| Shares Outstanding (Mil) | 37.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Icure Pharmaceutical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Icure Pharmaceutical Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Icure Pharmaceutical Inc Frequently Asked Questions
What is Icure Pharmaceutical Inc(XKRX:175250)'s stock price today?
The current price of XKRX:175250 is â‚©1818.00. The 52 week high of XKRX:175250 is â‚©3595.00 and 52 week low is â‚©1775.00.
When is next earnings date of Icure Pharmaceutical Inc(XKRX:175250)?
The next earnings date of Icure Pharmaceutical Inc(XKRX:175250) is 2024-05-27 Est..
Does Icure Pharmaceutical Inc(XKRX:175250) pay dividends? If so, how much?
Icure Pharmaceutical Inc(XKRX:175250) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers